BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14512540)

  • 1. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.
    Iyasere C; Tilton JC; Johnson AJ; Younes S; Yassine-Diab B; Sekaly RP; Kwok WW; Migueles SA; Laborico AC; Shupert WL; Hallahan CW; Davey RT; Dybul M; Vogel S; Metcalf J; Connors M
    J Virol; 2003 Oct; 77(20):10900-9. PubMed ID: 14512540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.
    Younes SA; Yassine-Diab B; Dumont AR; Boulassel MR; Grossman Z; Routy JP; Sekaly RP
    J Exp Med; 2003 Dec; 198(12):1909-22. PubMed ID: 14676302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels.
    Boritz E; Palmer BE; Wilson CC
    J Virol; 2004 Nov; 78(22):12638-46. PubMed ID: 15507650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.
    Tilton JC; Luskin MR; Johnson AJ; Manion M; Hallahan CW; Metcalf JA; McLaughlin M; Davey RT; Connors M
    J Virol; 2007 Mar; 81(6):2713-25. PubMed ID: 17182676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
    Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function.
    Palmer BE; Boritz E; Wilson CC
    J Immunol; 2004 Mar; 172(5):3337-47. PubMed ID: 14978142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15.
    Seder RA; Grabstein KH; Berzofsky JA; McDyer JF
    J Exp Med; 1995 Oct; 182(4):1067-77. PubMed ID: 7561680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation, but not interleukin 2 production, of Gag-specific CD8+ T cells is associated with low HIV viremia and high CD4 counts in HIV-1-infected Chinese individuals.
    Li H; Chen X; Jin X; Liu Z; Huang X; Cao Z; Guo C; Dong T; Wu H
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):1-8. PubMed ID: 19584740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
    Emu B; Sinclair E; Favre D; Moretto WJ; Hsue P; Hoh R; Martin JN; Nixon DF; McCune JM; Deeks SG
    J Virol; 2005 Nov; 79(22):14169-78. PubMed ID: 16254352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
    Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
    Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.
    Jansen CA; De Cuyper IM; Steingrover R; Jurriaans S; Sankatsing SU; Prins JM; Lange JM; van Baarle D; Miedema F
    AIDS; 2005 Jul; 19(11):1145-54. PubMed ID: 15990567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.
    Seth N; Kaufmann D; Lahey T; Rosenberg ES; Wucherpfennig KW
    J Immunol; 2005 Nov; 175(10):6948-58. PubMed ID: 16272355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
    Keh CE; Shen JM; Hahn B; Hallahan CW; Rehm CA; Thaker V; Wynne SM; Davey RT; Lane HC; Sereti I
    AIDS; 2006 Feb; 20(3):361-9. PubMed ID: 16439869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.